Track the Calidi Biotherapeutics, Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €4m. The latest transaction was reported on 16 December 2025 (Cession). Among the most active insiders: Schoeneck James A. Every trade is free.
22
Insider Decl.
n/a
Thresholds
€391,800
4 ops.
Buy Volume
€16,457
2 ops.
Sell Volume
52Σ signal
Buys €391,800€16,457 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
7,709 shares@ US$1.80100.0% of flowCommon StockSEC:0001493152-23-046173:0
22 of 22 declarations
About Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc. is a company focused on developing biological therapies for cancer treatment. It employs innovative technologies to target and destroy tumor cells.